Thrombectomy Devices

This channel includes news and new technology innovations for catheter-based thrombectomy systems used to remove blood clots from vessels in the body. Thrombus removal a decade ago was a standard of care for acute coronary revascularization in ST-elevation myocardial infarction (STEMI). But, its use declined rapidly after several large trials showed no benefit. However today, thrombectomy is seeing increasing usage in new therapeutic areas to treat acute stoke, pulmonary embolism (PE), deep vein thrombosis (DVT) and venous thromboembolism (VTE). Thrombectomy is also referred to as embolectomy.

The types of thrombectomy systems include: 

   ● Ultrasound-assisted thrombolysis – Catheter-directed, high-frequency ultrasound helps thrombolytic agents penetrate clots to speed the action of fibrinolytic pharmacological therapy. 

   ● Rheolytic embolectomy – These devices inject pressurized saline through the catheter's distal tip and the macerated thrombus is aspirated through a catheter port. 

   ● Rotational embolectomy – A rotating device at the catheter tip is used to fragment the clot and fragments are aspirated by the catheter. 

   ● Aspiration thrombectomy – This includes manual clot aspiration or use of dedicated aspiration catheter devices that basically vacuum the clot out of the vessel. 

   ● Thrombus fragmentation – Thrombus can be mechanically disrupted by manually rotating a pigtail catheter or using balloon angioplasty, but this causes small fragments of emboli to flow distally. Dedicated devices also are available.

News | Thrombectomy Devices

Sept. 24, 2024 — Thrombolytic Science, LLC (TSI) has announced that the U.S. Food and Drug Administration (FDA) has ...

Home September 24, 2024
Home
News | Thrombectomy Devices

Sept. 5, 2024 - Prolocor, Inc. and Slingshot Biosciences recently announced the publication in Bioanalysis of the ...

Home September 10, 2024
Home
News | Stroke

Sept. 10, 2024 — Royal Philips and the World Stroke Organization (WSO) have published a policy paper calling for a ...

Home September 10, 2024
Home
News | Stroke

June 7, 2024 — Access to thrombectomy should be expanded to include patients who experience basilar artery occlusion ...

Home June 07, 2024
Home
News | FDA

April 24, 2024 — Expanse ICE announced today the ICE Aspiration System has received 510(k) clearance from the U.S. Food ...

Home April 24, 2024
Home
News | Thrombectomy Devices

January 16, 2024 — Penumbra, Inc., a thrombectomy company, has recently secured CE Mark (Conformité Européenne) for its  ...

Home January 16, 2024
Home
News | Stroke

January 23, 2023 — Imperative Care, Inc., announced U.S. Food and Drug Administration (FDA) 510(k) clearance of its Zoom ...

Home January 23, 2023
Home
News | Cardiovascular Business

January 11, 2023 — The Alameda, Calif.-based global healthcare company Penumbra has announced U.S. Food & Drug ...

Home January 11, 2023
Home
News | VIVA

October 31, 2022 — Results from the Late-Breaking Clinical Trials session at The VEINS Conference in Las Vegas, NV, were ...

Home October 31, 2022
Home
A rise in cardiovascular diseases has fueled technological advancements in thrombectomy devices
Feature | Thrombectomy Devices | By Global Market Insights

The global thrombectomy devices market is poised to experience substantial expansion, owing to the emergence of ...

Home June 27, 2022
Home
News | Catheters

May 10, 2022 — The MIVI Neuroscience Q Aspiration Catheter incorporates a novel pusher wire design on its proximal end ...

Home May 10, 2022
Home
News | Thrombectomy Devices

January 10, 2022 – Akura Medical Inc., a Shifamed portfolio company, announced the closing of its $25 million Series A1 ...

Home January 10, 2022
Home
The Viz.AI pulmonary embolism response team (PERT) app that uses AI to detect PE on images before they go into PACS, alerts the PERT team members and provides a mobile platform to message, review images and other patient data. Photo by Dave Fornell
Feature | Artificial Intelligence | By Dave Fornell, DAIC Editor

Artificial intelligence (AI) has found a unique niche to help automate the activation of acute care teams for pulmonary ...

Home December 09, 2021
Home
News | Pulmonary Embolism

August 9, 2021 — Boston Scientific Corp. has commenced enrollment in the HI-PEITHO clinical trial, a collaborative ...

Home August 09, 2021
Home
Subscribe Now